Maria L. Nicolosi

Catania, 95122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.

DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.

Journal: Biomolecules

Published: April 05, 2021

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation.

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation.

Journal: Cells

Published: August 05, 2019

Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.

Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: July 11, 2019

DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.

DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.

Journal: Endocrine-related cancer

Published: August 14, 2018

A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.

A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.

Journal: Cell adhesion & migration

Published: March 01, 2018

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Journal: Frontiers in endocrinology

Published: September 04, 2017

Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.

Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.

Journal: Oncotarget

Published: February 23, 2017

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

Journal: Frontiers in endocrinology

Published: November 23, 2016

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.

Journal: Oncotarget

Published: August 01, 2015

Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features.

Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 08, 2015

Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.

Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.

Journal: Oncotarget

Published: September 01, 2014

The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.

The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 03, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026